全文获取类型
收费全文 | 10298篇 |
免费 | 492篇 |
国内免费 | 56篇 |
专业分类
耳鼻咽喉 | 115篇 |
儿科学 | 176篇 |
妇产科学 | 221篇 |
基础医学 | 1183篇 |
口腔科学 | 259篇 |
临床医学 | 776篇 |
内科学 | 2801篇 |
皮肤病学 | 148篇 |
神经病学 | 1113篇 |
特种医学 | 298篇 |
外科学 | 1331篇 |
综合类 | 24篇 |
一般理论 | 3篇 |
预防医学 | 456篇 |
眼科学 | 204篇 |
药学 | 720篇 |
中国医学 | 14篇 |
肿瘤学 | 1004篇 |
出版年
2024年 | 9篇 |
2023年 | 64篇 |
2022年 | 144篇 |
2021年 | 264篇 |
2020年 | 164篇 |
2019年 | 211篇 |
2018年 | 241篇 |
2017年 | 213篇 |
2016年 | 241篇 |
2015年 | 260篇 |
2014年 | 351篇 |
2013年 | 525篇 |
2012年 | 759篇 |
2011年 | 783篇 |
2010年 | 420篇 |
2009年 | 409篇 |
2008年 | 714篇 |
2007年 | 760篇 |
2006年 | 747篇 |
2005年 | 702篇 |
2004年 | 692篇 |
2003年 | 615篇 |
2002年 | 553篇 |
2001年 | 67篇 |
2000年 | 56篇 |
1999年 | 51篇 |
1998年 | 109篇 |
1997年 | 75篇 |
1996年 | 78篇 |
1995年 | 76篇 |
1994年 | 73篇 |
1993年 | 63篇 |
1992年 | 42篇 |
1991年 | 30篇 |
1990年 | 35篇 |
1989年 | 29篇 |
1988年 | 18篇 |
1987年 | 22篇 |
1986年 | 21篇 |
1985年 | 16篇 |
1984年 | 19篇 |
1983年 | 18篇 |
1982年 | 17篇 |
1981年 | 24篇 |
1980年 | 11篇 |
1979年 | 7篇 |
1978年 | 8篇 |
1977年 | 5篇 |
1972年 | 5篇 |
1966年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
Paolo Palmisciano Gianluca Ferini Gina Watanabe Andie Conching Christian Ogasawara Gianluca Scalia Othman Bin-Alamer Ali S. Haider Maurizio Passanisi Rosario Maugeri Samer S. Hoz Matias Baldoncini Alvaro Campero Maurizio Salvati Aaron A. Cohen-Gadol Giuseppe E. Umana 《Current oncology (Toronto, Ont.)》2022,29(7):4842
Background: Craniovertebral junction (CVJ) schwannomas are rare, with surgery and stereotactic radiosurgery (SRS) being effective yet challenging options. We systematically reviewed the literature on CVJ schwannomas. Methods: PubMed, Scopus, Web-of-Science, and Cochrane were searched following the PRISMA statement to include studies reporting CVJ schwannomas. Clinical features, management, and outcomes were analyzed. Results: We collected 353 patients from 101 included articles. Presenting symptoms were mostly neck pain (30.3%) and headache (26.3%), with most cranial neuropathies involving the XII (31.2%) and X (24.4%) nerves. Most tumors originated from C2 (30.9%) and XII (29.4%) nerves, being extracranial (45.1%) and intradural-extradural (44.2%). Erosion of C1–C2 vertebrae (37.1%), the hypoglossal canal (28.3%), and/or jugular foramen (20.1%) were noted. All tumors were operated, preferably with the retrosigmoid approach (36.5%), with the far-lateral approach (29.7%) or with the posterior approach and cervical laminectomy (26.9%), far-lateral approaches (14.2%), or suboccipital craniotomy with concurrent cervical laminectomy (14.2%). Complete tumor resection was obtained most frequently (61.5%). Adjuvant post-surgery stereotactic radiosurgery was delivered in 5.9% patients. Median follow-up was 27 months (range, 12–252). Symptom improvement was noted in 88.1% of cases, and cranial neuropathies showed improvement in 10.2%. Post-surgical complications occurred in 83 patients (23.5%), mostly dysphagia (7.4%), new cranial neuropathies (6.2%), and cerebrospinal fluid leak (5.9%). A total of 16 patients (4.5%) had tumor recurrence and 7 died (2%), with median overall survival of 2.7 months (range, 0.1–252). Conclusions: Microsurgical resection is safe and effective for CVJ schwannomas. Data on SRS efficacy and indications are still lacking, and its role deserves further evaluation. 相似文献
82.
83.
Maurizio Fattorutto Sandrine Tourreau-Pham Elisabeth Mazoyer Philippe Bonnin Martine Raphaël Françoise Morin Michel Cupa Charles-Marc Samama 《Journal canadien d'anesthésie》2004,51(7):672-679
PURPOSE: To compare the effects of recombinant activated factor VII (rFVIIa) and platelet-rich plasma (PRP) in an experimental model of bleeding and arterial thrombosis. METHODS: The Folts model was used in 60 rabbits. After anesthesia, the carotid artery was exposed and a 75% stenosis was induced. A compression injury of the artery triggered a series of cyclic flow reductions (CFRs). After counting baseline CFRs, animals were assigned randomly to one of four groups (n = 15 in each): control, PRP, rFVIIa and placebo. Control animals received 10 mL.kg(-1) of saline while 10 mL.kg(-1) of a hydroxyethyl starch solution (200,000/6%/0.5) were infused in the three other groups. CFRs were measured again, followed by treatment with PRP, rFVIIa or placebo and by a final measurement of CFRs. At the end of each observation period, an ear immersion bleeding time (BT) was measured and a blood sample was drawn for the evaluation of hematological variables. Microvascular bleeding was evaluated at the end of the experiment in grams of blood shed from liver and spleen sections. Results are presented as median (range). RESULTS: rFVIIa shortened the BT and decreased microvascular bleeding as compared with placebo [60 (35-100) sec vs 110 (50-140) sec, P = 0.0019 and 9 (4-24) g vs 17 (5-28) g, P = 0.002, respectively]. rFVIIa did not increase CFRs [3(0-9) vs |(0-5), P = 0.11]. CONCLUSION: rFVIIa led to a decrease in BT and microvascular bleeding but did not significantly affect arterial thrombosis in rabbits. 相似文献
84.
Raffaela Fuccelli Maria Vittoria Sepporta Patrizia Rosignoli Guido Morozzi Maurizio Servili 《Nutrition and cancer》2013,65(8):1322-1330
The aim of this study was to investigate the ability of epoxides of styrene (styrene-7,8-oxide; SO) and 1,3-butadiene (3,4-epoxy-1-butene; 1,2:3,4:-diepoxybutane) to cause oxidative stress and oxidative DNA damage on human peripheral blood mononuclear cells (PBMCs) and whether a complex mixture of olive oil phenols (OOPE) could prevent these effects. The DNA damage was measured by the single-cell gel electrophoresis (SCGE; comet assay). We found that the DNA damage induced by alkene epoxides could be prevented by N-acetyl-cysteine (10 mM) and catalase (100 U/ml). Alkene epoxides caused a significant (P < 0.05) increase of both peroxide concentration in extra- and intracellular environment and formamidopyrimidine DNA glycosylase (FPG)- and Endonuclease III (ENDO III)-sensitive sites in PBMCs, demonstrating the presence of oxidized bases. OOPE (1 μg of total phenols/ml) was able to prevent the alkene epoxide induced DNA damage both after 2 and 24 h of incubation. In addition, OOPE completely inhibited the SO-induced intracellular peroxide accumulation in PBMCs and prevented the oxidative DNA damage induced by SO, as evidenced by the disappearance of both FPG- and ENDO III-sensitive sites. This is the first study demonstrating the ability of OOPE to prevent the DNA damage induced by alkene epoxides providing additional information about the chemopreventive properties of olive oil. 相似文献
85.
86.
87.
88.
89.
Filaci G Fravega M Setti M Traverso P Millo E Fenoglio D Negrini S Ferrera F Romagnoli A Basso M Contini P Rizzi M Ghio M Benatti U Damonte G Ravetti JL Carmignani G Zanetti M Indiveri F 《Blood》2006,107(4):1505-1512
Telomerase is considered a universal tumor-associated antigen (TAA) due to its high rate of expression by cancers (approximately 90%), and clinical trials are in progress to test the immunotherapeutical efficacy of antitelomerase immunization in patients with cancer. However, the data concerning frequency and functional activity of telomerase-specific cytotoxic T lymphocytes (CTLs) in patients with cancer are few and conflicting, although their knowledge would be mandatory to predict the efficacy of telomerase-specific immunotherapy in selected patients. We performed this study to analyze frequency and cytolytic function of circulating CD8+ T lymphocytes specific for the p540 telomerase peptide in a series of human leukocyte antigen (HLA)-A2+ cancer patients. The results show that most patients with cancer have circulating telomerase-specific CD8+ T lymphocytes, but a high frequency of telomerase-specific CTLs are present only in a fraction of them. Furthermore, CTL lines able to kill telomerase-positive tumor cells, including autologous cancer cells, can be expanded ex vivo from some, but not all, patients with cancer. In conclusion, the results of the study support the development of clinical protocols using telomerase peptides as an immunizing agent. However, they underline the necessity to study single patients immunologically before undergoing vaccination, to select the patients adequately, and to eventually adapt the immunization schedule to the patient's immunologic status. 相似文献
90.